Oncosil Medical Ltd (OSL) — Cash Flow Reinvestment Rate
Oncosil Medical Ltd (OSL) has a Cash Flow Reinvestment Rate of 0.07x as of June 2015, reinvesting AU$43.85K (capex AU$43.85K ) from operating cash flow of AU$596.28K. Explore OSL capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncosil Medical Ltd Cash Flow Reinvestment Rate (2006–2010)
Historical reinvestment intensity for Oncosil Medical Ltd across 2 annual periods. Also explore balance sheet size of Oncosil Medical Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Oncosil Medical Ltd (2006–2010)
Year-by-year capital reinvestment analysis for Oncosil Medical Ltd. For live market cap and broader valuation context, see Oncosil Medical Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.20x | AU$30.48K | AU$154.35K | AU$30.48K | ▼ -85.8% |
| 2006 | 1.39x | AU$271.11K | AU$195.51K | AU$271.11K | — |